# A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine

> **NCT01740284** · PHASE3 · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 46 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis

## Interventions

- **DRUG:** Grazax + Aerius
- **DRUG:** Grazax + placebo

## Key facts

- **NCT ID:** NCT01740284
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2013-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01740284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01740284, "A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01740284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*